Crystal Stevens alleged she is permanently disabled from the surgery, as she must recline most of the time and depends on her husband for simple tasks such as tying her shoes, according to the report.
Brett Oppenheimer, attorney for Ms. Stevens, said the Infuse bone graft was implanted in an “off-label” and unpermitted surgery, according to the report. Infuse is FDA-approved but only for a specific spine surgery performed through the abdomen, which is not the surgery Ms. Stevens underwent.
Medtronic officials said they do not comment on pending litigation, while Norton Healthcare officials have not yet received the complaint.
Mr. Oppenheimer said in the report he and fellow attorney David Gray plan to file several more lawsuits on behalf of patients who allege similar complications from procedures that used Infuse devices.
More Articles on Hospital Lawsuits:
Highmark Drops False Advertising Suit Against UPMC
15 Recent Lawsuits Involving Hospitals
Indiana Court Ruling on Hospital Costs Could Result in Flood of Million-Dollar Lawsuits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
